Skip to content

European Registry of Dialysis Treatment of Pediatric Acute Kidney Injury (AKI)

European Registry of Dialysis Treatment of Pediatric Acute Kidney Injury (AKI)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02960867
Acronym
EurAKID
Enrollment
1892
Registered
2016-11-10
Start date
2016-04-30
Completion date
2019-04-30
Last updated
2019-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Keywords

paediatric, kidney

Brief summary

Acute kidney injury (AKI) is a frequent clinical condition in hospitalized, in particular, in critically ill children. Moreover, AKI is an independent predictor of mortality. An incidence of AKI in pediatric intensive care units (PICU) between 10 and 62% has been reported in recent clinical trials adopting pRIFLE or AKIN criteria, with the highest risk present in cardiac surgery patients. Despite significant developments in the management of AKI, the overall mortality rate of patients with AKI has not improved significantly. Currently, there is no consensus concerning the optimum dialysis modalities to adopt in pediatric AKI. No studies have prospectively compared the efficacy of different types of RRT for pediatric AKI. While PD remains the most commonly used modality in children worldwide, over the last decade CRRT has become the preferred treatment modality for critically ill children with AKI in North America. The investigators have recently conducted a survey among 34 European Pediatric Nephrology Centers in the ESCAPE Network to obtain current information on dialysis management practices in children. Approximately 900 children with AKI requiring dialysis are managed at these 34 centers per year. This number supports the creation of a prospective European AKI registry.

Detailed description

The main scope of the Registry is to report the epidemiology and outcome of children with AKI treated with dialysis in over 30 Pediatric Nephrology Centers in Europe. Secondary aims are to verify the association of a specific dialysis modality with the outcome and the association of primary disease, co-morbidities, nephrotoxic agents, fluid overload, anuria, basic hemodynamic parameters (BP, HR), basic nutritional intakes (protein and calorie supply) with the outcome. Data capture will be exclusively web-based via electronic case report forms. Every participating site will be provided with a unique code and password that identify the corresponding site.

Interventions

None listed

Sponsors

Baxter Healthcare Corporation
CollaboratorINDUSTRY
Mariella Enoc
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children with AKI at Hospital admission or who developed AKI during hospitalization treated with dialysis (PD, HD, CRRT) * Age: 0-18 yrs

Exclusion criteria

* Children with known preexisting CKD (i.e.: AKI on CKD)

Design outcomes

Primary

MeasureTime frameDescription
incidence of AKI requiring dialysis in PICU and non-PICU children3 yearsurine output and serum creatinine

Secondary

MeasureTime frameDescription
difference in mortality related to dialysis modality3 yearsCRRT modality (CVVH, CVVHD, CVVHDF)
difference in the primary outcome related to duration of mechanical ventilation3 yearsduration of mechanical ventilation
difference in the primary outcome related to severity score3 yearsseverity score
Mortality rates3 yearsmortality
difference in the primary outcome related to FiO23 yearsFiO2
difference in the primary outcome related to Mean Airway Pressure3 yearsMean Airway Pressure
difference in the primary outcome related to paO23 yearspaO2
difference in the primary outcome related to SpO23 yearsSpO2

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026